Organization

Longeveron Inc.

About

As a clinical-stage biotechnology company, Longeveron develops cellular therapies for chronic diseases associated with aging and other additional life-threatening conditions. Lomecel-B, the company's lead investigational product, derives from culture-expanded medicinal signaling cells (MSCs) isolated from the donated bone marrow of young healthy adults. By utilizing young healthy donors, Longeveron has a goal to develop safe and effective cell therapies for some of the most extreme and difficult conditions that are associated with aging.

Overview

Founded 2014
Type Public
Location Miami, Florida, USA

Stock

LGVN $3.81 -10.77% $(0.46)

Latest News

Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket Sep 28, 2022 Benzinga Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday. Silo Pharma, Inc. (NASDAQ: SILO)...
Longeveron Names Jerome Bailey Vice President of Business Operations Sep 15, 2022 GlobeNewswire Inc. Executive brings more than 30 years of global biopharmaceutical operations and program management experience Executive brings more than 30 years of global biopharmaceutical operations and...
Longeveron to Announce Second Quarter 2022 Financial Results on August 12, 2022 Aug 08, 2022 GlobeNewswire Inc. Live conference call on Friday, August 12 at 8:30 a.m. EST Live conference call on Friday, August 12 at 8:30 a.m. EST
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday Jul 08, 2022 Benzinga Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq...
This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session Jul 07, 2022 Benzinga Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings...